Paper1691027
Raynaud's syndrome.
Cooke ED and 1 other. BMJ, 1990. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Raynaud's syndrome. Papers, record 1691027. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1691027
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Raynaud Disease | Major topic |
| Angiotensin-Converting Enzyme Inhibitors | |
| Cardiovascular Agents | |
| Epoprostenol | |
| Female | |
| Humans | |
| Iloprost | |
| Moxisylyte | |
| Nifedipine |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 2344496 | Raynaud's syndrome. | https://conductscience.org/library/papers/2344496 | PubMed |
| Comment in | 2344545 | Raynaud's syndrome. | https://conductscience.org/library/papers/2344545 | PubMed |
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2941573 | Selective antagonism of S2-serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon. | J Rheumatol | 1986 | https://conductscience.org/library/papers/2941573 | PubMed |
| 2 | 6411898 | Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid. | J Pharmacol Exp Ther | 1983 | https://conductscience.org/library/papers/6411898 | PubMed |
| 3 | 3307894 | Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis. | Br J Dermatol | 1987 | https://conductscience.org/library/papers/3307894 | PubMed |
| 4 | 2447572 | Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis. | Postgrad Med J | 1987 | https://conductscience.org/library/papers/2447572 | PubMed |
| 5 | 3322358 | The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon. | Br J Dermatol | 1987 | https://conductscience.org/library/papers/3322358 | PubMed |
| 6 | 2449871 | Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. | Ann Rheum Dis | 1988 | https://conductscience.org/library/papers/2449871 | PubMed |
| 7 | 6416474 | Role of cold and emotional stress in Raynaud's disease and scleroderma. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6416474 | PubMed |
| 8 | 6316965 | Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 omega 3). | Biochem Biophys Res Commun | 1983 | https://conductscience.org/library/papers/6316965 | PubMed |
| 9 | 6318123 | Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. | Nature | 1984 | https://conductscience.org/library/papers/6318123 | PubMed |
| 10 | 6432198 | Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6432198 | PubMed |
| 11 | 2860386 | Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenon. | Lancet | 1985 | https://conductscience.org/library/papers/2860386 | PubMed |
| 12 | 4025925 | Influence of the menstrual cycle on Raynaud's phenomenon and on cold tolerance in normal women. | Angiology | 1985 | https://conductscience.org/library/papers/4025925 | PubMed |
| 13 | 2412780 | Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. | Drugs | 1985 | https://conductscience.org/library/papers/2412780 | PubMed |
| 14 | 4083568 | CL115,347, an analogue of prostaglandin E2. Peripheral circulatory effects of single ascending doses administered transdermally in normal subjects and in patients with Raynaud's phenomenon. | Angiology | 1985 | https://conductscience.org/library/papers/4083568 | PubMed |
| 15 | 4087271 | Induced vasodilation as a home treatment for Raynaud's disease. | J Rheumatol | 1985 | https://conductscience.org/library/papers/4087271 | PubMed |
| 16 | 3081460 | Double-blind randomized trial of nitroderm TTS in the treatment of Raynaud's phenomenon. | Isr J Med Sci | 1986 | https://conductscience.org/library/papers/3081460 | PubMed |
| 17 | 3280190 | Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. | Clin Immunol Immunopathol | 1988 | https://conductscience.org/library/papers/3280190 | PubMed |
| 18 | 2454140 | Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue. | Br J Rheumatol | 1988 | https://conductscience.org/library/papers/2454140 | PubMed |
| 19 | 3054105 | Fish oils--their significance to human health. | J R Soc Med | 1988 | https://conductscience.org/library/papers/3054105 | PubMed |
| 20 | 3207617 | Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis. | Br J Dermatol | 1988 | https://conductscience.org/library/papers/3207617 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8882128 | Increased capillary permeability in systemic sclerosis: help or hindrance? | Ann Rheum Dis | 1996 | https://conductscience.org/library/papers/8882128 | PubMed |
| 2344545 | Raynaud's syndrome. | BMJ | 1990 | https://conductscience.org/library/papers/2344545 | PubMed |
| 2344496 | Raynaud's syndrome. | BMJ | 1990 | https://conductscience.org/library/papers/2344496 | PubMed |
| 2060571 | Once daily felodipine in patients with primary Raynaud's phenomenon. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/2060571 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1691027
GET https://conductscience.org/api/papers/v1/1691027/references?page=2